KIT and gastrointestinal stromal tumor: Most importantly, the expression of FGFR2 was significantly increased in IM-treated GIST T-1R cells (Figure 4A—middle panel, B), revealing the activation of FGFR2-mediated signaling in KIT-inhibited GISTs.